Exploring Biopharma, Safety Tech, and Resource Revolutions with Reviva, Sharps Technology, and American Resources Corp

Save
2 years ago
4
Reviva biopharmaceutical central nervous system respiratory diseases metabolic diseases drug candidates RP5063 Brilaroxazine RP1208 Phase 3 clinical-stage schizophrenia treatment

This week’s episode of the RedChip Money Report includes interviews with senior executives from Sharps Technology (NASDAQ: STSS), Reviva Pharmaceuticals (NASDAQ: RVPH) & American Resources Corporation (NASDAQ: AREC). Visit RedChip.com to learn more.

Loading comments...